INNA TINSLEY: Open Payments
NPI 1851642425 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 18 payments from 10 companies in 2025. Trend: 2023 $1,348 · 2024 $873 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $80 |
| Novo Nordisk Inc | 3 | $67 |
| Esperion Therapeutics, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: The Cologuard Plus Collection Kit, Rybelsus, NEXLETOL, AIRSUPRA, TRUMENBA, Dojolvi, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across MD — which companies pay providers there.
